Literature DB >> 23712071

Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: comparison with brain tau.

Akio Yamazaki1, Yuji Nishizawa, Isao Matsuura, Fumio Hayashi, Jiro Usukura, Vladimir A Bondarenko.   

Abstract

Recent studies have suggested a possible involvement of abnormal tau in some retinal degenerative diseases. The common view in these studies is that these retinal diseases share the mechanism of tau-mediated degenerative diseases in brain and that information about these brain diseases may be directly applied to explain these retinal diseases. Here we collectively examine this view by revealing three basic characteristics of tau in the rod outer segment (ROS) of bovine retinal photoreceptors, i.e., its isoforms, its phosphorylation mode and its interaction with microtubules, and by comparing them with those of brain tau. We find that ROS contains at least four isoforms: three are identical to those in brain and one is unique in ROS. All ROS isoforms, like brain isoforms, are modified with multiple phosphate molecules; however, ROS isoforms show their own specific phosphorylation pattern, and these phosphorylation patterns appear not to be identical to those of brain tau. Interestingly, some ROS isoforms, under the normal conditions, are phosphorylated at the sites identical to those in Alzheimer's patient isoforms. Surprisingly, a large portion of ROS isoforms tightly associates with a membranous component(s) other than microtubules, and this association is independent of their phosphorylation states. These observations strongly suggest that tau plays various roles in ROS and that some of these functions may not be comparable to those of brain tau. We believe that knowledge about tau in the entire retinal network and/or its individual cells are also essential for elucidation of tau-mediated retinal diseases, if any.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AD; AP; Alzheimer's disease; BSA; Cdk5; DTT; FTDP-17; MT; MW; Microtubule-associated proteins; Neurodegenerative diseases; PDE; PHF; PMSF; Pγ; ROS; Retinal degenerative diseases; Tau; Tα; alkaline phosphatase; bovine serum albumin; cGMP phosphodiesterase; cyclin-dependent protein kinase 5; dithiothreitol; front-temporal dementia with parkinsonism liked to chromosome; isoelectric point; microtubule; molecular weight; pI; paired helical filament; phenylmethylsulfonyl fluoride; rod outer segments of retinal photoreceptors; the inhibitory subunit of cGMP phosphodiesterase; the α subunit of retinal G protein

Mesh:

Substances:

Year:  2013        PMID: 23712071      PMCID: PMC3724453          DOI: 10.1016/j.bbadis.2013.05.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  67 in total

1.  Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.

Authors:  N Sergeant; J P David; D Lefranc; P Vermersch; A Wattez; A Delacourte
Journal:  FEBS Lett       Date:  1997-08-04       Impact factor: 4.124

Review 2.  Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure.

Authors:  Peter Wostyn; Kurt Audenaert; Peter Paul De Deyn
Journal:  Clin Neurol Neurosurg       Date:  2007-12-03       Impact factor: 1.876

3.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.

Authors:  A Delacourte; N Sergeant; A Wattez; D Gauvreau; Y Robitaille
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

4.  Localization of caveolin-1 in photoreceptor synaptic ribbons.

Authors:  S Kachi; A Yamazaki; J Usukura
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

Review 5.  Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.

Authors:  Jian-Zhi Wang; Yi-Yuan Xia; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.

Authors:  D P Hanger; J C Betts; T L Loviny; W P Blackstock; B H Anderton
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

7.  Expression of serine/threonine protein-kinases and related factors in normal monkey and human retinas: the mechanistic understanding of a CDK2 inhibitor induced retinal toxicity.

Authors:  Grazia Saturno; Manuela Pesenti; Cristiano Cavazzoli; Anna Rossi; Anna M Giusti; Berthold Gierke; Michael Pawlak; Miro Venturi
Journal:  Toxicol Pathol       Date:  2007-12       Impact factor: 1.902

8.  Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina.

Authors:  K U Löffler; D P Edward; M O Tso
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-01       Impact factor: 4.799

9.  Ocular manifestations of Alzheimer's disease in animal models.

Authors:  Miles Parnell; Li Guo; Mohamed Abdi; M Francesca Cordeiro
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

Review 10.  The MAP2/Tau family of microtubule-associated proteins.

Authors:  Leif Dehmelt; Shelley Halpain
Journal:  Genome Biol       Date:  2004-12-23       Impact factor: 13.583

View more
  1 in total

Review 1.  Neurodegenerative Proteinopathies in the Proteoform Spectrum-Tools and Challenges.

Authors:  Aneeqa Noor; Saima Zafar; Inga Zerr
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.